Human infection with highly pathogenic avian influenza A (H5N1) virus: review of clinical issues.
This article provides an updated review of the clinical issues related to human infection with highly pathogenic avian influenza A (H5N1) virus. The clinical data available to date are presented, as well as recent findings on the pathogenesis of and antiviral treatment and immunotherapy for H5N1 virus infection in humans and animal models.
Uyeki
Timothy M
TM
Epidemiology and Prevention Branch, Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. tuyeki@cdc.gov
D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D053124:Influenza A Virus, H5N1 Subtype / Q000302:isolation & purification*; D007251:Influenza, Human / Q000188:drug therapy / Q000473:pathology* / Q000503:physiopathology / Q000821:virology*
D000998:Antiviral Agents